Pages that link to "Q68253101"

The following pages link to Metalloproteinases in degenerative aortic disease (Q68253101):

Displaying 44 items.

• Recent Advances in the Development of Experimental Animal Models Mimicking Human Aortic Aneurysms (Q26798395) (← links)
• Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. (Q35093966) (← links)
• Regulation of matrix metalloproteinases: an overview (Q35584927) (← links)
• Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms (Q35747748) (← links)
• Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages (Q35750610) (← links)
• MMP-2 Isoforms in Aortic Tissue and Serum of Patients with Ascending Aortic Aneurysms and Aortic Root Aneurysms (Q36179263) (← links)
• Collagenase and surgical disease (Q36594887) (← links)
• The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases (Q36600699) (← links)
• Magnetically Responsive Bone Marrow Mesenchymal Stem Cell-Derived Smooth Muscle Cells Maintain Their Benefits to Augmenting Elastic Matrix Neoassembly (Q36786066) (← links)
• Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis? (Q36799135) (← links)
• Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers (Q37312000) (← links)
• Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. (Q37347147) (← links)
• Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model (Q37385378) (← links)
• Endothelial cell proteases: physiological role and regulation (Q40390590) (← links)
• Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas (Q41062476) (← links)
• Pathogenesis of abdominal aortic aneurysms--cellular and biochemical mechanisms (Q41288569) (← links)
• Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine (Q42173811) (← links)
• Is there a role for biomarkers in thoracic aortic aneurysm disease? (Q47871544) (← links)
• Sex Differences in Abdominal Aortic Aneurysms (Q49921149) (← links)
• Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. (Q52507754) (← links)
• Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). (Q52534168) (← links)
• Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm (Q57445690) (← links)
• Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease (Q57605907) (← links)
• Free radical pathways in the inflammatory response (Q57943745) (← links)
• Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease (Q58624202) (← links)
• Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase (Q71093820) (← links)
• Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms (Q71218618) (← links)
• Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall (Q71657591) (← links)
• Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture (Q71726512) (← links)
• Elastase-induced matrix degradation in arterial organ cultures: an in vitro model of aneurysmal disease (Q71765023) (← links)
• In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta (Q72057993) (← links)
• Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease (Q72390494) (← links)
• Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells (Q72820997) (← links)
• Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta (Q73025879) (← links)
• Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm (Q73342673) (← links)
• Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms (Q73422910) (← links)
• Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta (Q73676314) (← links)
• Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease (Q74336866) (← links)
• Prevalence of true vein graft aneurysms: implications for aneurysm pathogenesis (Q74590671) (← links)
• Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines (Q77655778) (← links)
• Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases (Q77682968) (← links)
• Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms (Q77773046) (← links)
• Isolation and identification of a major metabolite of PNU-107859, an MMP inhibitor from the biliary fluid of rats (Q77960282) (← links)
• Differences in ultrasound-derived arterial wall stiffness parameters and noninvasive blood pressure between Friesian horses and Warmblood horses (Q89595050) (← links)